ACTA1
protein-codingactin alpha 1, skeletal muscle, the group of Actins
Gene summary
The product encoded by this gene belongs to the actin family of proteins, which are highly conserved proteins that play a role in cell motility, structure and integrity. Alpha, beta and gamma actin isoforms have been identified, with alpha actins being a major constituent of the contractile apparatus, while beta and gamma actins are involved in the regulation of cell motility. This actin is an alpha actin that is found in skeletal muscle. Mutations in this gene cause a variety of myopathies, including nemaline myopathy, congenital myopathy with excess of thin myofilaments, congenital myopathy with cores, and congenital myopathy with fiber-type disproportion, diseases that lead to muscle fiber defects with manifestations such as hypotonia. [provided by RefSeq, Sep 2019]
- ACTA
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~3.7 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0015735
Submitter: Orphanet
Inheritance Pattern: SD
Disease ID:MONDO:0020342
Submitter: Illumina
Inheritance Pattern: AR
Disease ID:MONDO:0019951
Submitter: Orphanet
Inheritance Pattern: Unknown
Disease ID:MONDO:0019949
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0008070
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0014800
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0008070
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0015738
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0859523
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0100084
Submitter: ClinGen
Actinopathy is a musculoskeletal system disorder that covers a wide spectrum of phenotypes and is caused by pathogenic variants in the skeletal muscle α-actin gene, *ACTA1*. These variants lead to a variety of overlapping adult onset and congenital myopathies characterized by muscle weakness, hypotonia, myopathic facies, respiratory dysfunction, and rarely cardiac involvement. While nemaline myopathy is the most common presentation, several other myopathies have been reported in association with *ACTA1* mutations. Specific skeletal muscle structural lesions visible on muscle biopsy include actin accumulations, nemaline and intranuclear bodies, fiber-type disproportion, cores, caps, dystrophic features and zebra bodies. Disorders associated with *ACTA1* pathogenic variants can have autosomal dominant (90%) or recessive (10%) inheritance. Per criteria outlined by the Lumping and Splitting Working Group, we found differences in molecular mechanism (dominant negative vs. recessive loss of function) and inheritance pattern actinopathy was split into dominant and recessive curations. The dominant curation includes phenotypes across a spectrum of disease including typical and severe infantile congenital myopathy as well as scapulohumeroperoneal myopathy (OMIM 616852, 161800, 620278). *ACTA1* was first reported in relation to dominant actinopathy in 1999 (Nowak KJ, et al., 1999, PMID: 10508519). At least 190 unique variants (predominantly missense) have been reported in humans. Evidence supporting this gene-disease relationship includes case-level data, segregation data, and experimental data. Variants in this gene have been reported in at least 21 probands in 7 publications (PMIDs: 10508519, 25938801, 15468086, 15520409, 20303757, 25747004, 15198992). Variants in this gene segregated with disease in at least 25 additional family members. More evidence is available in the literature, but the maximum score for genetic evidence has been reached. In vitro studies suggest that abnormal folding, altered polymerization and aggregation of mutant actin isoforms are common properties of dominant *ACTA1* variants. Some of these effects are mutation-specific, and likely result in variations in the severity of muscle weakness seen in individual patients and to the common pathological hallmarks in skeletal muscle. This gene disease association is supported by its biochemical function in muscle contraction (PMID: 21314430), its skeletal muscle specific expression (PMID: 1743394), the functional alteration of contractility in patient cells (PMID: 29328520) and two knock-in mouse models (PMIDs: 21303860, 22067542) that recapitulate human disease. In summary *ACTA1* is definitively associated with dominant inheritance of actinopathy. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time.
Inheritance Pattern: AD
Disease ID:MONDO:0009711
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0015737
Submitter: Orphanet
Inheritance Pattern: SD
Disease ID:MONDO:0100084
Submitter: PanelApp Australia
Inheritance Pattern: SD
Disease ID:MONDO:0008070
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0015736
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0008070
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0100084
Submitter: ClinGen
Actinopathy is a musculoskeletal system disorder that covers a wide spectrum of phenotypes and is caused by pathogenic variants in the skeletal muscle α-actin gene, *ACTA1*. These variants lead to a variety of overlapping adult onset and congenital myopathies characterized by muscle weakness, hypotonia, myopathic facies, respiratory dysfunction, and rarely cardiac involvement. While nemaline myopathy is the most common presentation, several other myopathies have been reported in association with *ACTA1* mutations. Specific skeletal muscle structural lesions visible on muscle biopsy include actin accumulations, nemaline and intranuclear bodies, fiber-type disproportion, cores, caps, dystrophic features and zebra bodies. Disorders associated with *ACTA1* pathogenic variants can have autosomal dominant (90%) or recessive (10%) inheritance. Per criteria outlined by the Lumping and Splitting Working Group, we found differences in molecular mechanism (dominant negative vs. recessive loss of function) and inheritance pattern actinopathy was split into dominant and recessive curations. *ACTA1* was first reported in relation to recessive actinopathy in 1999 (Nowak KJ, et al., 1999, PMID: 10508519). Evidence supporting this gene-disease relationship includes case-level data, segregation data, and experimental data. Biallelic loss of function variants (splicing, frameshift, nonsense, and missense) in this gene have been reported in at least 7 probands in 5 publications (PMIDs: 10508519, 12921789, 15236405, 17187373, 24447884). Variants in this gene segregated with disease in at least 4 additional family members. More evidence may be available in the literature, but the maximum score for genetic evidence has been reached. This gene disease association is supported by its biochemical function in muscle contraction (PMID: 21314430), its skeletal muscle specific expression (PMID: 1743394), and a null mouse model (PMID: 12138199) that partially recapitulates human disease. In summary *ACTA1* is definitively associated with recessive inheritance of actinopathy. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time.
Clinical Genomic Database (CGD)
Manifestation: Musculoskeletal; Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to ACTA1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001100.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 7 | 92 | 99 | |||
| missense | 84 | 130 | 181 | 395 | ||
| nonsense | 6 | 5 | 11 | |||
| start loss | 3 | 3 | ||||
| frameshift | 8 | 9 | 3 | 20 | ||
| splice donor/acceptor (+/-2bp) | 3 | 6 | 1 | 10 | ||
| Total | 101 | 150 | 195 | 92 | 0 | 538 |
Highest pathogenic variant AF is 0.000021706719
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001091.1 | 6 | MANE Select | |
| Ensembl | ENSP00000355645.3 | 6 | MANE Select | |
| Ensembl | ENSP00000355644.4 | 6 | Standard | |
| Ensembl | ENSP00000355644.4 | 6 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| acta1b | Danio rerio | Structure: skeletal muscle cell Quality: decreased amount abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Myometrial Relaxation and Contraction Pathways
- Fas Ligand (FasL) pathway and Stress induction of Heat Shock Proteins (HSP) regulation
- Association Between Physico-Chemical Features and Toxicity Associated Pathways
- Striated Muscle Contraction
- erk and pi-3 kinase are necessary for collagen binding in corneal epithelia
Biological Process
- muscle contraction
- response to mechanical stimulus
- response to extracellular stimulus
- response to lithium ion
- positive regulation of gene expression
Molecular Function
- structural constituent of cytoskeleton
- protein binding
- ATP binding
- myosin binding
- ADP binding
Cellular Component
- stress fiber
- extracellular space
- cytosol
- striated muscle thin filament
- actin filament
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000366684
- Coding exons
- 6
- Length
- 2854
- Individuals with no LoFs
- 125706
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 42
- Defined
- 125748
- p
- 0.000167
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 4.53 | 55 | 261 | 0.211 | 0.0000176 | 2498 |
| Missense (PolyPhen) | 22 | 126.98 | 0.17325 | 1140 | ||
| Synonymous | 1.11 | 102 | 117 | 0.870 | 0.00000992 | 744 |
| Loss of Function | 0.934 | 11 | 14.9 | 0.739 | 6.45e-7 | 161 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0.00014 | 0.00014 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.000054 | 0.000054 | rare |
| Finnish | 0.000093 | 0.000092 | rare |
| European (Non-Finnish) | 0.00020 | 0.00018 | rare |
| South Asian | 0.00042 | 0.00039 | rare |
| Other | 0.00016 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Actins are highly conserved proteins that are involved in various types of cell motility and are ubiquitously expressed in all eukaryotic cells.;
- Disease
- DISEASE: Nemaline myopathy 3 (NEM3) [MIM:161800]: A form of nemaline myopathy. Nemaline myopathies are muscular disorders characterized by muscle weakness of varying severity and onset, and abnormal thread-like or rod-shaped structures in muscle fibers on histologic examination. {ECO:0000269|PubMed:10508519, ECO:0000269|PubMed:11166164, ECO:0000269|PubMed:11333380, ECO:0000269|PubMed:15198992, ECO:0000269|PubMed:15236405, ECO:0000269|PubMed:15336687, ECO:0000269|PubMed:15520409, ECO:0000269|PubMed:16427282, ECO:0000269|PubMed:16945537, ECO:0000269|PubMed:17705262, ECO:0000269|PubMed:22442437, ECO:0000269|PubMed:23650303, ECO:0000269|PubMed:25938801}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Myopathy, actin, congenital, with excess of thin myofilaments (MPCETM) [MIM:161800]: A congenital muscular disorder characterized at histological level by areas of sarcoplasm devoid of normal myofibrils and mitochondria, and replaced with dense masses of thin filaments. Central cores, rods, ragged red fibers, and necrosis are absent. {ECO:0000269|PubMed:10508519}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Myopathy, congenital, with fiber-type disproportion (CFTD) [MIM:255310]: A genetically heterogeneous disorder in which there is relative hypotrophy of type 1 muscle fibers compared to type 2 fibers on skeletal muscle biopsy. However, these findings are not specific and can be found in many different myopathic and neuropathic conditions. {ECO:0000269|PubMed:15468086, ECO:0000269|PubMed:17387733}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Myopathy, scapulohumeroperoneal (SHPM) [MIM:616852]: An autosomal dominant muscular disorder characterized by progressive muscle weakness with initial scapulo-humeral-peroneal and distal distribution. Over time, muscle weakness progresses to proximal muscle groups. Clinical characteristics include scapular winging, mild lower facial weakness, foot drop due to foot eversion and dorsiflexion weakness, and selective muscle atrophy. Age at onset and disease progression are variable. {ECO:0000269|PubMed:25938801}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.937
Intolerance Scores
- LoFtool
- 0.244
- RVIS EVS
- -0.3
- RVIS percentile EVS
- 32.62
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.824
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |